olinvacimab: Clinical Trials

3 trials of olinvacimab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Unknown 2, Completed 1

Follow olinvacimab: new trials by email Literature Review of olinvacimab trials Research Report on olinvacimab

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
TTAC-0001 and Pembrolizumab Combination phase1b Trial in Recurrent Glioblastoma
TTAC-0001 and pembrolizumab combination - Recurrent Glioblastoma
Phase 1UnknownPharmAbcine92019-01-162022-08-17
TTAC-0001 and Pembrolizumab Phase Ib Combination Trial in Metastatic Triple-negative Breast Cancer
TTAC-0001 and pembrolizumab combination - Triple Negative Breast Cancer
Phase 1UnknownPharmAbcine112019-01-032022-08-17
Phase I Trial of Tanibirumab in Advanced or Metastatic Cancer
Tanibirumab - Advanced Cancer, Metastatic Cancer
Phase 1CompletedPharmAbcine262011-11-012014-01-29

Conditions studied

Glioblastoma (1)  ·  Neoplasm Metastasis (1)  ·  Triple Negative Breast Neoplasms (1)

Sponsors

PharmAbcine (3)

Countries

Australia (2)  ·  South Korea (1)

Top investigators

Young Seok Park, MD, PhD (1)